Keynote Speaker profiles
This page is currently under construction, please check back soon!!
Dr Miguel Constância
Department of Obstetrics & Gynaecology,
The University of Cambridge, UK
Imprinting and Foetal Growth
Dr. Constancia received his PhD in Developmental Biology from Cambridge University in 2000. He did his doctoral studies and a short postdoctoral program in Dr. Wolf Reik’s laboratory at the Babraham Institute in Cambridge (2000-2003). He subsequently started his own group at the Babraham Institute with the award of career development fellowships. In 2007 he was appointed Assistant Professor of Reproductive Biology, Department of Obstetrics & Gynaecology (www.obgyn.cam.ac.uk) at the University of Cambridge where he leads a group working on epigenetics and imprinting, with a focus on fetal growth and metabolic disease in later life. Dr. Constancia is a faculty member of the Institute of Metabolic Science (www.mrl.ims.cam.ac.uk), Centre of Trophoblast Research (www.trophoblast.cam.ac.uk) and a NET member of the EU Epigenome Network of Excellence (www.epigenome-noe.net). Dr. Constancia work has led to important insights on how imprinted genes control allocation of maternal resources and discovered novel mechanisms by which imprinted genes are epigenetically regulated.
Prof Terri Wood
NJMS-UH Cancer Center Newark, USA
IGF system in Breast Cancer
Dr. Wood received her Ph.D. from UCLA and conducted postdoctoral training at SUNY, Stony Brook and Columbia University. Dr. Wood is a University Professor and holds the Rena Warshow Endowed Chair in Multiple Sclerosis in the Department of Neurology & Neuroscience at the New Jersey Medical School/UMDNJ. Dr. Wood has a long-standing research program and publication record in the biology and signaling of the insulin-like growth factors in normal development, disease and cancer. She has had many years of continuous funding from the NIH and is a member of NIH grant review panels and several editorial boards.
The overall goal of her research is to elucidate mechanisms and signaling pathways involved in proliferation, differentiation and survival of neural progenitor and mammary epithelial cells. These pathways are investigated during normal development and in specific diseases or pathologies including neural injury and cancer.
|
